Philippines - anglais - FDA (Food And Drug Administration)

broadchem philippines biopharma corporation - inactivated actinobacillus pleuropneumoniae , bordetella bronchiseptica , pasteurella multocida , actinobacillus pleuropneumoniae toxoid vaccine (vet.) - emulsion for injection (im) - formulation: each ml (dose) contains: actinobacillus pleuropneumoniae serotype 2 and 9 …………………..≥ 1 rp bordetella bronchiseptica serotype 9 …………………..≥ 1 rp pasteurella multocida serotype 625/a and 115/d…………………..≥ 1 rp actinobacillus pleuropneumoniae (apx i, ii and iii toxin)…………………..≥ 1 rp rp relative potency

Philippines - anglais - FDA (Food And Drug Administration)

farmline agriventures, inc.; distributor: farmline agriventures, inc. - inactivated pasteurella multocida vaccine (vet.) - emulsion for injection (sc) - formulation: each 0.5 ml (dose) contains: pasteurella multocida, serotypes 1, 3 and 4 sat - serum agglutination test ≥ 7.3 log2 sat

Irlande - anglais - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - pasteurella haemolytica type a1 strain nl 1009 - lyophilisate and solvent for emulsion for injection - bovine - immunological - inactivated vaccine

Irlande - anglais - HPRA (Health Products Regulatory Authority)

intervet ireland limited - inactivated bovine respiratory syncytial virus strain ev908; inactivated parainfluenza-3-virus, strain sf-4 reisinger; inactivated mannheimia (pasteurella) haemolyticaa1, strain m4/1 - suspension for injection - . - bovine parainfluenza virus + bovine respiratory syncytial virus + pasteurella - cattle - immunological - inactivated vaccine

Nouvelle-Zélande - anglais - Ministry for Primary Industries

zoetis new zealand limited - pasteurella multocida (inactivated) - pasteurella multocida (inactivated) 0 vaccine - vaccine

États-Unis - anglais - NLM (National Library of Medicine)

teva pharmaceuticals usa inc - linezolid (unii: isq9i6j12j) (linezolid - unii:isq9i6j12j) - linezolid 600 mg - linezolid is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below. linezolid is not indicated for the treatment of gram-negative infections. it is critical that specific gram-negative therapy be initiated immediately if a concomitant gram-negative pathogen is documented or suspected [see warnings and precautions (5.4) ]. nosocomial pneumonia caused by staphylococcus aureus (methicillin-susceptible and -resistant isolates) or streptococcus pneumoniae [see clinical studies (14) ]. community-acquired pneumonia caused by streptococcus pneumoniae , including cases with concurrent bacteremia, or staphylococcus aureus (methicillin-susceptible isolates only) [see clinical studies (14) ]. complicated skin and skin structure infections, including diabetic foot infections, without concomitant osteomyelitis , caused by staphylococcus aureus (methicillin-susceptible and -resistant isolates), streptococcus pyogenes , or strept

États-Unis - anglais - NLM (National Library of Medicine)

aphena pharma solutions - tennessee, llc - ciprofloxacin hydrochloride (unii: 4ba73m5e37) (ciprofloxacin - unii:5e8k9i0o4u) - ciprofloxacin 500 mg - ciprofloxacin tablets are indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions and patient populations listed below. please see dosage and administration  for specific recommendations. urinary tract infections caused by escherichia coli, klebsiella pneumoniae, enterobacter cloacae, serratia marcescens, proteus mirabilis, providencia rettgeri, morganella morganii, citrobacter diversus, citrobacter freundii, pseudomonas aeruginosa, methicillin-susceptible staphylococcus epidermidis, staphylococcus saprophyticus, or enterococcus faecalis. acute uncomplicated cystitis in females caused by escherichia coli or staphylococcus saprophyticus. chronic bacterial prostatitis caused by escherichia coli or proteus mirabilis. lower respiratory tract infections caused by escherichia coli, klebsiella pneumoniae, enterobacter cloacae, proteus mirabilis, pseudomonas aeruginosa, haemophilus influenzae, haemophilus parainfluenzae, or penicillin-suscept

Belgique - anglais - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

intervet international b.v. - bordetella bronchiseptica (inactivated) ; pasteurella multocida d0 protein - emulsion for injection - pasteurella multocida; bordetella bronchiseptica - bordetella + pasteurella - pig

Belgique - anglais - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

intervet international - bordetella bronchiseptica (inactivated) = 8,0 log2/do agglutiantietiter; pasteurella multocida d0 protein = 4,0 log2/dose toxin-neutralising antibody titre - emulsion for injection - pasteurella multocida anatoxine; pasteurella multocida; bordetella bronchiseptica - bordetella + pasteurella - pig

Australie - anglais - APVMA (Australian Pesticides and Veterinary Medicines Authority)

apvma permit - pasteurella multocida+vaccine - coryza - vaccine